Source: International Congress 2014 – Beyond tyrosine kinase inhibition: promising new developments in molecular oncology
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
P. Micke (Uppsala, Sweden). Genome-wide chip arrays from diagnostic specimens as the basis for therapy. International Congress 2014 – Beyond tyrosine kinase inhibition: promising new developments in molecular oncology

Member's Comments

No comment yet.

Related content which might interest you: Micro Array screening of microRNA markers of interstitial lung diseases for differential diagnostics. Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Practical approaches to analysis of DNA microarrays Source: Annual Congress 2004 - PG7 - Application of genomics and proteomics to pulmonary disease Year: 2004 The detection of EGFR mutations in liquid biopsy by allele-specific qPCR – the comparative evaluation of two common diagnostic tests Source: International Congress 2018 – Genetics in chronic pulmonary diseases Year: 2018 A pooling based genome-wide analysis identifies new potential candidate genes for atopy in the echrs study Source: Annual Congress 2009 - Asthma genetics: from genome wide to single nucleotide polymorphisms Year: 2009 Identification of disease genes by expression profiling Source: Eur Respir J 2001; 18: 882-889 Year: 2001 A data management and analysis platform for RASP-UK multiomics clinical datasets Source: Virtual Congress 2021 – Exacerbations of chronic respiratory diseases, including SARS-CoV-2 Year: 2021 Serum microRNA signatures identified in a genome-wide profiling predict the mortality of patients with sepsis Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections Year: 2011 Benchtop NMR-based metabolomic analysis as a diagnostic tool for tuberculosis in clinical urine samples Source: International Congress 2019 – Tuberculosis: diagnosis Year: 2019 Microdissection and cDNA arrays can be combined by RNA preamplification for a cell-type specific expression profiling Source: Eur Respir J 2001; 18: Suppl. 33, 161s Year: 2001 Next-generation sequencing and assessment of tumour mutational burden: are these tools ready for clinical routine use? Source: International Congress 2019 – Molecular profiling and personalised treatment concepts in advanced non-small cell lung cancer: pertinent clinical dilemmas Year: 2019 Identification of reference genes in lung cancer from RNA-seq data Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench Year: 2017 Versatile workflow for storage, characterization and celltype resolved transcriptional and epigenetic profiling of human lung samples Source: ERS Lung Science Conference 2020 Year: 2020 Versatile workflow for storage, characterization and celltype resolved transcriptional and epigenetic profiling of human lung samples Source: Virtual Congress 2020 – Reflections from the Lung Science 2020 conference Year: 2020 Overview on diagnostic studies Source: ERS Course 2015 Year: 2015 Metabolomic profiling of clinical sputum samples reveals novel biomarkers for the early identification of lung cancer patients Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Non-targeted integrative multi-omics approaches on sputum reveal potential diagnostic and monitoring biomarkers for respiratory diseases Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 A comparative study of conventional preparation, thin prep and cell block in cytologic specimens of lung diseases Source: Eur Respir J 2004; 24: Suppl. 48, 81s Year: 2004 Transcriptome sequencing (RNA-Seq) of human endobronchial biopsies: asthma versus controls Source: Eur Respir J 2013; 42: 662-670 Year: 2013